Objective: To describe our experience with coblation technology for facial resurfacing Methods: Retrospective chart review of all patients treated with coblation at our institution Results: Twenty-four patients (22 female) underwent a total of 29 coblation procedures for aging face (n = 21) or acne scarring (n = 3). The perioral region was the most frequently treated aesthetic subunit (n = 14), followed by the lower eyelid (n = 7). Five patients underwent full-face coblation. Three patients underwent a second coblation procedure for aging face while a single patient with severe acne scarring underwent 3 procedures. Repeat coblation was delayed at least 5 months (mean, 9 months). Seventeen coblation procedures (59%) were performed concurrently with procedures including, but not limited to, injection treatment, rhinoplasty, blepharoplasty, or combined face/ necklift; no adverse events occurred. Seven procedures, including a fufl-face coblation, were performed in the office under local anesthesia and oral sedation without any adverse events. Mean follow-up was 6 months (range, 1 week to 24 months). No complications were observed. Al patients were satisfied with the results after their final coblation treatment. Conclusions: Facial coblation is a safe and effective treatment modality for facial resurfacing.
|Original language||English (US)|
|Journal||MedGenMed Medscape General Medicine|
|State||Published - Aug 18 2008|
ASJC Scopus subject areas